BETA

VACCINE RESEARCH INSTITUTE OF SAN DIEGO: Form 990EZ, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
VACCINE RESEARCH INSTITUTE OF SAN DIEGO (EIN 33-0903864)
Tax period
2020-07-01 to 2021-06-30
Filed
2022-05-13
IRS object ID
202201339349205520
Schema version
2020v4.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-05-13T15:42:52-07:00ReturnTs
Tax Period End2021-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN952076568PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Leaf & Cole LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line12810 Camino Del Rio South Suite 200AddressLine1Txt
CitySan DiegoCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92108ZIPCd
FieldValueIRS element (for citing)
Return Type990EZReturnTypeCd
Tax Period Begin2020-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN330903864EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1VACCINE RESEARCH INSTITUTE OF SAN DIEGOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlVACCBusinessNameControlTxt
Phone8585813960PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line13030 BUNKER HILL STAddressLine1Txt
CitySAN DIEGOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92109ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJOHN WELSH PHDPersonNm
Person TitleCEOPersonTitleTxt
Signature2022-05-13SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstJOHN WELSHPersonFirstNm
Person LastPHDPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLATONYA M KNOXPreparerPersonNm
PTINP00513874PTIN
Phone6192947200PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
Federated Assurance LevelFAL1FederatedAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990-EZ IRS990EZ

FieldValueIRS element (for citing)
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Schedule B Not RequiredYes (X)ScheduleBNotRequiredInd
Website Addresswww.vrisd.orgWebsiteAddressTxt
Organization501c3Yes (X)Organization501c3Ind
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Gross Receipts$2,015GrossReceiptsAmt
Info In Schedule O Part IYes (X)InfoInScheduleOPartIInd
Contributions Gifts Grants Etc$426ContributionsGiftsGrantsEtcAmt
Investment Income$3InvestmentIncomeAmt
Sale Of Assets Gross$1,586SaleOfAssetsGrossAmt
Cost Or Other Basis Expense Sale$0CostOrOtherBasisExpenseSaleAmt
Gain Or Loss From Sale Of Assets$1,586GainOrLossFromSaleOfAssetsAmt
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Special Events Direct Expenses$0SpecialEventsDirectExpensesAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt
Total Revenue$2,015TotalRevenueAmt
Occupancy Rent Utlts And Maint$5,992OccupancyRentUtltsAndMaintAmt
Other Expenses Total$10,611OtherExpensesTotalAmt
Total Expenses$16,603TotalExpensesAmt
Excess Or Deficit For Year-$14,588ExcessOrDeficitForYearAmt
Net Assets Or Fund Balances BOY$35,377NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$20,789NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIYes (X)InfoInScheduleOPartIIInd

Cash Savings And Investments CashSavingsAndInvestmentsGrp

FieldValueIRS element (for citing)
BOY$8,428BOYAmt
EOY$2,208EOYAmt

Land And Buildings LandAndBuildingsGrp

FieldValueIRS element (for citing)
BOY$14,366BOYAmt
EOY$12,676EOYAmt

Other Assets Total Detail OtherAssetsTotalDetail

FieldValueIRS element (for citing)
BOY$17,256BOYAmt
EOY$6,740EOYAmt

Form990 Total Assets Form990TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$40,050BOYAmt
EOY$21,624EOYAmt

Sum Of Total Liabilities SumOfTotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$4,673BOYAmt
EOY$835EOYAmt

Net Assets Or Fund Balances NetAssetsOrFundBalancesGrp

FieldValueIRS element (for citing)
BOY$35,377BOYAmt
EOY$20,789EOYAmt
FieldValueIRS element (for citing)
Primary Exempt PurposeOUR MISSION IS SCIENTIFIC RESEARCH FOCUSING ON DEVELOPMENT OF PREVENTATIVE AND THERAPEUTIC TREATMENTS FOR BOTH INFECTIOUS (MAALARIA, HEPATITIS B AND C, AND INFLUENZA) AND NON-INFECTIOUS DISEASES (CANCER AND CARDIOVASCULAR DISEASE).PrimaryExemptPurposeTxt

Program Srvc Accomplishment ProgramSrvcAccomplishmentGrp

FieldValueIRS element (for citing)
Description Program Srvc AccomOur mission is scientific research focusing on development of preventative and therapeutic treatments for both infectious (malaria, hepatitis B and C, and influenza) and non-infectious diseases (cancer and cardiovascular disease).These studies involve the development of new cancer therapeutics as well as prophylactic and therapeutic vaccines. The goal is to bring to fruition treatments for diseases which have plagued millions of people worldwide and to share these results with the scientific community and the public.To accomplish these goals the VRISD has recruited and will continue to recruit researchers with expertise in Molecular Biology, Pharmacogenomics, Peptide Chemistry, Bioinformatics, Oncology and Immunology. These areas of expertise will allow us to gain an understanding of the host-pathogen and host-tumor interactions as they relate to effective therapeutic design. VRISD scientists are working together for the purpose of eradicating diseases that have eluded researchers and physicians in the past, with the ultimate goal of providing better health for all people worldwide.DescriptionProgramSrvcAccomTxt
Grants And Allocations$11,931GrantsAndAllocationsAmt
FieldValueIRS element (for citing)
Total Program Service Expenses$11,931TotalProgramServiceExpensesAmt

Officer Director Trustee Empl OfficerDirectorTrusteeEmplGrp (4 entries)

TitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmt
JOHN WELSH PHD
CEO40.00$1,760
DAVID R MILICH PHD
Chairman2.00$0
RANDY HORTON
Director1.00$0
TERRY DILLMAN
Director1.00$0
FieldValueIRS element (for citing)
Activities Not Previously RptfalseActivitiesNotPreviouslyRptInd
Chg Made To Orgnzng Doc Not RptfalseChgMadeToOrgnzngDocNotRptInd
Organization Had UBIfalseOrganizationHadUBIInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Organization Dissolved EtcfalseOrganizationDissolvedEtcInd
Form1120 Pol FiledfalseForm1120PolFiledInd
Made Loans To From OfficersfalseMadeLoansToFromOfficersInd
Tax Imposed Under IRC4911$0TaxImposedUnderIRC4911Amt
Tax Imposed Under IRC4912$0TaxImposedUnderIRC4912Amt
Tax Imposed Under IRC4955$0TaxImposedUnderIRC4955Amt
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
Tax Imposed On Organization Mgr$0TaxImposedOnOrganizationMgrAmt
Tax Reimbursed By Organization$0TaxReimbursedByOrganizationAmt
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonLEAH JOHNSONPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line13030 BUNKER HILL STAddressLine1Txt
CitySAN DIEGOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92109ZIPCd
FieldValueIRS element (for citing)
Phone8585813960PhoneNum
FieldValueIRS element (for citing)
Foreign Financial AccountfalseForeignFinancialAccountInd
Foreign OfficefalseForeignOfficeInd
Donor Advised FndsfalseDonorAdvisedFndsInd
Operate HospitalfalseOperateHospitalInd
Tanning Services ProvidedfalseTanningServicesProvidedInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
School OperatingfalseSchoolOperatingInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Part VI Of Comp Of Hghst Pd EmplNONEPartVIOfCompOfHghstPdEmplTxt
Part VI Hghst Pd Cntrct Prof SrvcNONEPartVIHghstPdCntrctProfSrvcTxt
Filed Schedule AYes (true)FiledScheduleAInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,031,384CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$767,219CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$450,609CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$98,519CurrentTaxYearMinus1YearAmt
Current Tax Year$426CurrentTaxYearAmt
Total$2,348,157TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,031,384CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$767,219CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$450,609CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$98,519CurrentTaxYearMinus1YearAmt
Current Tax Year$426CurrentTaxYearAmt
Total$2,348,157TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$2,272,719SubstantialContributorsTotAmt
Public Support Total170$75,438PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$212CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$224CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$205CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$80CurrentTaxYearMinus1YearAmt
Current Tax Year$3CurrentTaxYearAmt
Total$724TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$2,348,881TotalSupportAmt
Public Support CY1700.03210PublicSupportCY170Pct
Public Support PY1700.30380PublicSupportPY170Pct
Ten Pct Facts Crcmstncs Test PYYes (X)TenPctFactsCrcmstncsTestPYInd
Facts And Circumstances TestPrior Year Facts and Circumstances: From 2017 through 2022, VRISD scientists applied for 29 grants from the National Institutes of Health, several from the Department of Defense, and published 45 papers, over topics ranging from Alzheimers disease to prostate cancer. Obtaining funding has been very challenging, and we have not been funded by a public grant since 2017. The organization had hoped that funding from Pellficure Inc. would help bridge the gap between NIH and DOD grants. From the point of view of public benefit, Pellficure Inc. had defined research goals and many of the staff of VRISD worked toward accomplishing those goals, and findings from those studies have been published in publicly accessible literature, thereby accruing public benefit. That work focused on studying the properties of a natural product, plumbagin, that many scientists think may have therapeutic value in treating cancer. Pellficure has a limited intellectual property position regarding plumbagins use in treating prostate cancer. The basic science worked out along the way and published was not performed to support Pellficures property goals. The organization also worked on several projects unrelated to the objectives of Pellficure Inc., including a project to develop a gene signature for the adaptation of metastatic prostate cancer to bone marrow, for which a manuscript is under preparation, and which will serve as a grant application subject in the near future. The organization has also been working on a sequencing technology that was funded through 2017 by the National Cancer Center and will soon be advanced enough to request Phase II funding. While extensive efforts to achieve public funding during the Pellficure period were unsuccessful, the focus and emphasis continues to be to perform basic publicly funded research on important public health problems, and there are several projects in mid-stage development that will develop into NIH, NCI, and DOD grant applications this year, as well as possibly smaller funding sources.FactsAndCircumstancesTestTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (15 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Other Expenses.1008Interest $178
Other Expenses.1009Depreciation $1690
Other Expenses.1012Insurance $2316
Other Expenses.1RELOCATION COSTS $3180
Other Expenses.2LICENSE AND FILING FEES $1008
Other Expenses.3SUPPLIES $830
Other Expenses.4OUTSIDE SERVICES $502
Other Expenses.5REPAIR AND MAINTENANCE $292
Other Expenses.6PATENT, LEGAL AND TAXES $217
Other Expenses.7BANK FEES $164
Other Expenses.8TELEPHONE $134
Other Expenses.9DUES & SUBSCRIPTIONS $100
Other Assets.1005Accounts Receivable - Beginning $12344 Accounts Receivable - Ending $6286
Other Assets.1DEPOSITS - Beginning $4912 DEPOSITS - Ending $454
Total Liabilities.1001Accounts Payable and Accrued Expenses - Beginning $4673 Accounts Payable and Accrued Expenses - Ending $835

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.